Published in Eur Radiol on September 19, 2013
Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme. Eur Radiol (2014) 0.97
Comparison between breast MRI and contrast-enhanced spectral mammography. Med Sci Monit (2015) 0.91
Clinical utility of dual-energy contrast-enhanced spectral mammography for breast microcalcifications without associated mass: a preliminary analysis. Eur Radiol (2015) 0.91
The quality of tumor size assessment by contrast-enhanced spectral mammography and the benefit of additional breast MRI. J Cancer (2015) 0.90
Mammography: an update of the EUSOBI recommendations on information for women. Insights Imaging (2016) 0.84
Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation. Eur Radiol (2016) 0.77
Optimization of contrast-enhanced spectral mammography depending on clinical indication. J Med Imaging (Bellingham) (2014) 0.75
Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results. Med Sci Monit (2016) 0.75
Clinical study of contrast-enhanced digital mammography and the evaluation of blood and lymphatic microvessel density. Br J Radiol (2016) 0.75
Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study. Eur Radiol (2016) 0.75
Quantification of breast lesion compositions using low-dose spectral mammography: A feasibility study. Med Phys (2016) 0.75
Gold silver alloy nanoparticles (GSAN): an imaging probe for breast cancer screening with dual-energy mammography or computed tomography. Nanoscale (2016) 0.75
A Case of a Concurrent and Co-Located Invasive Carcinoma and a Fibroadenoma to Illustrate the Potential of Dual-Energy, Contrast-Enhanced Digital Mammography on the Diagnosis of Complex Breast Lesions. Iran J Radiol (2016) 0.75
Preclinical study of diagnostic performances of contrast-enhanced spectral mammography versus MRI for breast diseases in China. Springerplus (2016) 0.75
[Diagnostic imaging of breast cancer : An update]. Radiologe (2016) 0.75
"Staging of breast cancer and the advanced applications of digital mammogram: what the physician needs to know?" Br J Radiol (2017) 0.75
Quantitative contrast-enhanced spectral mammography based on photon-counting detectors: A feasibility study. Med Phys (2017) 0.75
Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med (2005) 14.47
Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology (2002) 7.48
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology (2011) 5.17
Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg (2002) 3.43
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer (2010) 2.62
Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol (2008) 2.52
Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology (1999) 2.11
Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model. Radiology (2009) 2.02
Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg (2008) 2.01
Dual-energy contrast-enhanced digital subtraction mammography: feasibility. Radiology (2003) 1.98
MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol (2003) 1.50
Contrast-enhanced digital mammography: initial clinical experience. Radiology (2003) 1.49
Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study. Breast Cancer Res (2012) 1.38
MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat (2007) 1.31
Dual-energy contrast-enhanced digital mammography: initial clinical results. Eur Radiol (2010) 1.28
Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology (2012) 1.22
Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography. AJR Am J Roentgenol (2006) 1.18
Does size matter? Comparison study between MRI, gross, and microscopic tumor sizes in breast cancer in lumpectomy specimens. Int J Clin Exp Pathol (2010) 1.17
Contrast-enhanced digital mammography. Eur J Radiol (2008) 1.17
Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. Eur J Radiol (2006) 1.14
Digital mammography using iodine-based contrast media: initial clinical experience with dynamic contrast medium enhancement. Invest Radiol (2005) 1.10
The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat (2010) 1.07
MRI versus ultrasonography and mammography for preoperative assessment of breast cancer. Am Surg (2009) 1.05
Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J Pathol (1998) 1.04
Evaluation of contrast-enhanced digital mammography. Eur J Radiol (2009) 1.02
The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast. Eur J Surg Oncol (2007) 1.01
Role of breast MRI in the preoperative evaluation of patients with newly diagnosed breast cancer. AJR Am J Roentgenol (2009) 0.90
Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T. Radiology (2002) 0.89
Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best? Ann Surg Oncol (2010) 0.87
Contrast enhanced cartilage imaging: Comparison of ionic and non-ionic contrast agents. Eur J Radiol (2007) 0.82
Pre-operative estimation of primary breast cancer size: a comparison of clinical assessment, mammography and ultrasound. Breast (2001) 0.80
A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med (1988) 5.32
Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection. Lancet (1987) 3.68
Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg (2011) 2.91
Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med (1997) 2.88
320-slice CT neuroimaging: initial clinical experience and image quality evaluation. Br J Radiol (2009) 2.15
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol (2000) 1.95
Computerized analysis of breast lesions in three dimensions using dynamic magnetic-resonance imaging. Med Phys (1998) 1.66
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option? Eur J Cancer (2004) 1.52
Quality indicators in breast cancer care. Eur J Cancer (2010) 1.46
[Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience]. Gastroenterol Clin Biol (1999) 1.45
[Sonographic detection of microcalcifications - potential of new method]. Ultraschall Med (2012) 1.42
Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer (2000) 1.38
International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol (2001) 1.28
Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology (2001) 1.27
A specific domain in alpha-catenin mediates binding to beta-catenin or plakoglobin. J Cell Sci (1997) 1.26
Analysis of spiculation in the computerized classification of mammographic masses. Med Phys (1995) 1.26
Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis? Eur J Endocrinol (2010) 1.18
Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib. Ann Oncol (2009) 1.15
Differentiation between benign and malignant findings on MR-mammography: usefulness of morphological criteria. Eur Radiol (2001) 1.13
Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol (2002) 1.12
A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene (1996) 1.12
Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab (2005) 1.11
Breast elasticity: principles, technique, results: an update and overview of commercially available software. Eur J Radiol (2012) 1.10
Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol (2009) 1.05
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety. Ann Oncol (2011) 1.04
Variation of HMGB1 expression in breast cancer. Anticancer Res (2002) 1.04
Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg (2008) 1.03
Breast elastography: the technical process and its applications. Diagn Interv Imaging (2013) 1.03
Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q. Br J Cancer (1998) 1.02
Diffuse idiopathic skeletal hyperostosis (DISH): relation to vertebral fractures and bone density. Osteoporos Int (2010) 1.00
Dose exposure of patients undergoing comprehensive stroke imaging by multidetector-row CT: comparison of 320-detector row and 64-detector row CT scanners. AJNR Am J Neuroradiol (2010) 1.00
Predicting cesarean delivery with decision tree models. Am J Obstet Gynecol (2000) 0.99
Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver. Eur J Surg Oncol (2009) 0.98
Significant differentiation of focal breast lesions: raw data-based calculation of strain ratio. Ultraschall Med (2011) 0.97
Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation). Ann Surg Oncol (2005) 0.97
Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients. Am J Transplant (2007) 0.96
Comparison between the minimum margin defined on preoperative imaging and the final surgical margin after hepatectomy for cancer: how to manage it? Ann Surg Oncol (2007) 0.94
Development of wound infections among women undergoing cesarean section. Obstet Gynecol (1988) 0.94
Early postoperative ultrasound of kidney transplants: evaluation of contrast medium dynamics using time-intensity curves. Rofo (2004) 0.93
Chemoembolization for liver metastases from medullary thyroid carcinoma. J Clin Endocrinol Metab (2006) 0.91
MRI of bone marrow disorders. Eur Radiol (2000) 0.91
The differential response to chemotherapy of ovarian metastases from colorectal carcinoma. Eur J Surg Oncol (2008) 0.90
[Sacroiliitis in children with spondyloarthropathy: therapeutic effect of CT-Guided intra-articular corticosteroid injection]. Rofo (2003) 0.90
ETA receptor blockade induces fibrosis of the clipped kidney in two-kidney-one-clip renovascular hypertensive rats. J Hypertens (2000) 0.88
Treatment of osteoid osteoma using CT-guided radiofrequency ablation versus MR-guided laser ablation: a cost comparison. Eur J Radiol (2012) 0.88
Spectrally inhomogeneous effects of contrast agents in breast lesion detected by high spectral and spatial resolution MRI. Acad Radiol (2002) 0.87
The distinction between benign and malignant liver tumors on sonography: value of a hypoechoic halo. AJR Am J Roentgenol (1992) 0.86
Cyclosporine absorption profiling and therapeutic drug monitoring using C(2) blood levels in stable renal allograft recipients. Transplant Proc (2002) 0.85
[Thoracic sarcoidosis]. Radiologe (1990) 0.84
[Comparing the visualization of microcalcifications with direct magnification in digital full-field mammography vs. film-screen mammography]. Rofo (2002) 0.83
[Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma]. Rofo (2004) 0.83
Histological findings in surgical specimens after core biopsy of the breast. Eur J Radiol (2002) 0.83
Detection of malignant and benign breast lesions with an automated US system: results in 120 cases. Radiology (1997) 0.83
Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy. J Clin Endocrinol Metab (2008) 0.83
[Intraoperative digital radiography for diagnosis of nonpalpable breast lesions]. Rofo (2000) 0.83
Diagnostic performance of a Near-Infrared Breast Imaging system as adjunct to mammography versus X-ray mammography alone. Eur Radiol (2011) 0.83
[Mammography screening in Germany]. Radiologe (2008) 0.83
Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo. Brain Res (1997) 0.83
Neurological outcome in 22 treated adolescents with hyperphenylalaninemia. A clinical and electrophysiological study. Acta Neurol Scand (1992) 0.83
Endocrine pancreatic tumours: which are the most useful MRI sequences? Eur Radiol (2010) 0.82
Cost comparison of nerve root infiltration of the lumbar spine under MRI and CT guidance. Eur Radiol (2013) 0.82
Functional and morphological deficits in late-treated patients with homocystinuria: a clinical, electrophysiologic and MRI study. Acta Neurol Scand (1991) 0.81
Topographic analysis and evaluation of anatomical landmarks for placement of central venous catheters based on conventional chest X-ray and computed tomography. Br J Anaesth (2013) 0.81
Use of iodine-based contrast media in digital full-field mammography--initial experience. Rofo (2003) 0.81
[Visualization of microcalcifications on mammographies obtained by digital full-field mammography in comparison to conventional film-screen mammography]. Rofo (2003) 0.81
Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan. Eur J Clin Chem Clin Biochem (1995) 0.80
Near monochromatic X-rays for digital slot-scan mammography: initial findings. Eur Radiol (2004) 0.80
Liposarcoma or lipoma: does genetics change classic imaging criteria? Eur J Radiol (2009) 0.80
Conversion from calcineurin inhibitors to sirolimus in kidney transplant patients reduces the urinary transforming growth factor-beta1 concentration. Transplant Proc (2007) 0.80
Normal intratumoral lymph node in a patient with lipoma mimicking liposarcoma. AJR Am J Roentgenol (2003) 0.79
Tissue transition projection (TTP) of the intestines. Eur Radiol (2000) 0.79
Protective effects of the mixed endothelin receptor antagonist bosentan in rats with CCL4-induced liver injury. J Cardiovasc Pharmacol (1995) 0.79
Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats. Cardiovasc Res (1996) 0.79
Swertia spp: a source of bitter compounes for medicinal use. Anc Sci Life (1996) 0.79
Role of the paracrine liver endothelin system in the pathogenesis of CCl4-induced liver injury. Eur J Pharmacol (1995) 0.79
Intraoperative specimen radiography in patients with nonpalpable malignant breast lesions. Rofo (2012) 0.79
AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast. Anal Quant Cytol Histol (2000) 0.79
[Automated mammary sonography and mammography: the differentiation of benign and malignant breast lesions]. Rofo (1998) 0.78
[Automated microscopic image analysis and the prognosis of preneoplasms and carcinomas of the mammary gland]. Gegenbaurs Morphol Jahrb (1989) 0.78
Volumetric breast density assessment: reproducibility in serial examinations and comparison with visual assessment. Rofo (2013) 0.78
[Workflow in digital screening mammography]. Radiologe (2008) 0.78
Different proliferation patterns in breast cancer: AgNOR measurements in ER-negative and ER-positive tumor cells. Anal Cell Pathol (2000) 0.78
[Frequency distribution, microscopic image analysis and grading of mammary carcinoma]. Zentralbl Pathol (1991) 0.78
Liposarcoma of the breast arising within a phyllodes tumor. J Comput Assist Tomogr (1999) 0.78
Paracrine renal endothelin system in rats with liver cirrhosis. Br J Pharmacol (1996) 0.78
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas. Oncology (2006) 0.78
Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study. Transplant Proc (2005) 0.78
[Sentinel node biopsy in breast carcinoma. Interdisciplinary agreement consensus of the German Society for Serology for quality controlled application in routine clinical testing]. Pathologe (2004) 0.77
[The role of blood-brain barrier in the pathogenesis of Alzheimer dementia--implications for immunological therapies for plaque dissolution]. Fortschr Neurol Psychiatr (2009) 0.77
Ovarian cysts in the fetus and neonate--changes in sonographic pattern in the follow-up and their management. Pediatr Radiol (1992) 0.77